Literature DB >> 1754292

Requirements and recommended dietary intakes of protein during infancy.

S J Fomon1.   

Abstract

Two approaches have been used to arrive at estimates of the requirement for protein by infants. The factorial approach consists of adding the requirement for growth to the requirement for replacement of inevitable losses in urine and feces and from the skin. Protein requirement estimated in this way was 1.98 g.kg-1.d-1 during the 1st mo of life and decreased rapidly to 1.18 g.kg-1.d-1 by 4 to 5 mo of age, then remained at about that level to age 1 y. Believing that protein intakes of the breast-fed infant are near the level of the requirement, researchers used the intakes of breast-fed infants as a second estimate of requirement. Although intakes of protein by breast-fed infants during the first 2 mo of life are generally similar to the requirement values estimated by the factorial approach, intakes from 2 to 6 mo of age are less than the requirement values estimated by the factorial approach. Possible explanations for the discrepancy are presented. Recommended dietary intakes of protein somewhat greater than the requirements estimated by the factorial approach are proposed. These recommended intakes are less than those proposed by the FAO/WHO/UNU "safe levels of protein intake" and are less than the Recommended Dietary Allowances of the Food and Nutrition Board.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1754292     DOI: 10.1203/00006450-199111000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Comparing apples with apples: it is time for standardized reporting of neonatal nutrition and growth studies.

Authors:  Barbara E Cormack; Nicholas D Embleton; Johannes B van Goudoever; William W Hay; Frank H Bloomfield
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

2.  The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.

Authors:  M Hoeksma; M Van Rijn; P H Verkerk; A M Bosch; M F Mulder; J B C de Klerk; T J de Koning; E Rubio-Gozalbo; M de Vries; P J J Sauer; F J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Optimal protein intake in healthy infants.

Authors:  Satish C Kalhan
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

Review 4.  Higher versus lower protein intake in formula-fed low birth weight infants.

Authors:  Tanis R Fenton; Shahirose S Premji; Heidi Al-Wassia; Reg S Sauve
Journal:  Cochrane Database Syst Rev       Date:  2014-04-21

5.  Clinical outcome and long-term management of 17 patients with propionic acidaemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier; P Parvy; J Bardet; P Kamoun; J M Saudubray
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

6.  Urea as a nutrient: bioavailability and role in nitrogen economy.

Authors:  A A Jackson
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

7.  Higher versus lower protein intake in formula-fed low birth weight infants.

Authors:  Tanis R Fenton; Heidi Al-Wassia; Shahirose S Premji; Reg S Sauve
Journal:  Cochrane Database Syst Rev       Date:  2020-06-23

8.  Recommendations for protein and amino acid intake in phenylketonuric patients.

Authors:  F Cockburn; B J Clark
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Increased kidney growth in formula-fed versus breast-fed healthy infants.

Authors:  Ida M Schmidt; Ida N Damgaard; Kirsten A Boisen; Claudia Mau; Marla Chellakooty; Klaus Olgaard; Katharina M Main
Journal:  Pediatr Nephrol       Date:  2004-08-11       Impact factor: 3.714

Review 10.  Protein metabolism in preterm infants with particular reference to intrauterine growth restriction.

Authors:  H A de Boo; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.